Bayer begins Phase II trial with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors Ruchika Sharma5 March 2025 9:00 AM ISTBerlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label clinical trial,...
Bayer-BlueRock Therapeutics bags USFDA Fast Track Designation for primary photoreceptor diseases treatment Ruchika Sharma3 March 2025 2:30 PM ISTBerlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, has announced that...
Bayer files for approval of extended 6 month treatment interval for Eylea 8 mg in EU Ruchika Sharma11 Feb 2025 11:30 AM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea...
Bayer seeks approval of finerenone in heart failure in EU Ruchika Sharma5 Feb 2025 11:30 AM ISTBerlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), seeking approval in...
Bayer seeks USFDA nod for Finerenone for adult patients with heart failure Ruchika Sharma11 Jan 2025 12:37 PM ISTBerlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration (US FDA) and to the...
Bayer partner seeks approval for Darolutamide plus androgen deprivation therapy for metastatic hormone sensitive prostate cancer Ruchika Sharma8 Jan 2025 12:30 PM ISTOrion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National Medical Products...
Federal Court brings end to Roundup litigation in Australia: Bayer Ruchika Sharma6 Jan 2025 10:00 AM ISTLeverkusen: Bayer has announced that the Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending...
Bayer acquires HiDoc Technologies, Cara Care app for irritable bowel syndrome Ruchika Sharma14 Dec 2024 4:00 PM ISTLeverkusen: Bayer has announced that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of...
Gilead Sciences ropes in Sanofi official Dietmar Berger as new Chief Medical Officer Ruchika Sharma13 Dec 2024 4:12 PM ISTFoster City: Gilead Sciences, Inc. has announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical...
Marksans Pharma Secures USFDA Nod for Generic Version of Clartin Tablet Farhat Nasim22 Nov 2024 3:03 PM ISTMarksans' product, Loratadine Tablets USP 10 mg are indicated for the treatment of allergic rhinitis.
Bayer receives USFDA Clearance for MEDRAD Centargo CT Injection System Ruchika Sharma10 Nov 2024 4:00 PM ISTWhippany: Bayer has announced 510 (k) clearance from the U.S. Food and Drug Administration (USFDA) for its MEDRAD Centargo CT Injection System, a...
Bayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart disease MD Bureau25 Oct 2024 3:34 PM ISTBerlin: Bayer has signed an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease program targeting patients with...
